COMMUNIQUÉS West-GlobeNewswire
-
Cosmos Health Share Buyback Surpasses 4.5 Million Shares; Continues Open Market Repurchases
15/07/2026 -
Sinopia Biosciences Publishes Preclinical Data in Science Translational Medicine Supporting SB-0110, a Novel PKA-II Modulator, for Parkinson's Disease
15/07/2026 -
RadioMedix Appoints Brian A. Markison to Board of Directors
15/07/2026 -
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine xx - 2025
15/07/2026 -
Hyperion DeFi Enters Agreement with Skew Technologies to Launch HIP-3 Perpetual Futures Market and Listing Service
15/07/2026 -
IPSEN - Buy-back programme - Art 5 of MAR - Week 28 - 2026
15/07/2026 -
Retrieve Medical Partners With Clear to Enhance Identity Verification For The Retrieve Medical Passport
15/07/2026 -
Rainwater Drake Dental Announces Name Change From Hawkins Rainwater Dental Group
15/07/2026 -
At 68, Nutrition World Founder Edward Jones Returns to the Bodybuilding Stage and Challenges Assumptions About Aging
15/07/2026 -
Nadia Care Named ACAP Preferred Vendor, Scaling Community-Centered, Culturally-Informed Care to Combat the Maternal Health Crisis
15/07/2026 -
New FDA-Cleared Single-Step Immunoblot IGeneX Tests Improve Early Detection of Lyme Disease, Study Finds
15/07/2026 -
Cynet Releases v4.33 Unveiling a New Cross-Site Dashboard and Enhanced SIEM Capabilities
15/07/2026 -
Lark Health Partners with Samsung to Bring AI-Powered Health Coach to U.S. Seniors
15/07/2026 -
NewcelX Granted Patent in Brazil for NCEL-101 in Type 1 Diabetes, Expanding Global IP Portfolio
15/07/2026 -
Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal Models
15/07/2026 -
Rectify Pharmaceuticals Announces Appointment of Constantine Chinoporos as Executive Chairman
15/07/2026 -
New Research Reveals Patient Frustrations With AI: When Patients Call, They Want To Reach a Person
15/07/2026 -
Omada Health to Host its First Investor Day on September 10, 2026
15/07/2026 -
Alembic Therapeutics LLC Announces Exclusive U.S. Distribution of NUVESSA® (metronidazole vaginal gel 1.3%)
15/07/2026
Pages